In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2

被引:174
作者
Okuma, T [1 ]
Honda, R [1 ]
Ichikawa, G [1 ]
Tsumagari, N [1 ]
Yasuda, H [1 ]
机构
[1] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo 1920392, Japan
关键词
D O I
10.1006/bbrc.1998.9995
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The SUMO-1 has been identified as a protein that is highly similar to ubiquitin and shown to conjugate to RanGAP1, PML, Sp200 and I kappa B alpha. The conjugation steps are thought to be similar to those of ubiquitination; and human Ubc9, which is homologous to the E2 enzyme for the ubiquitin conjugation step, was identified and shown to be necessary for the conjugation of SUMO-1 to its target protein. Other essential enzymes involved in this modification, however, remain to be clarified. Here we cloned human Sua1 (SUMO-1 activating enzyme) and hUba2, which are human homologs of yeast Saccharomyces cerevisiae Aos1 and Uba2, respectively. The recombinant proteins, Sua1p and hUba2p, formed a complex. In this complex, hUba2 bound SUMO-1 and this complex had the activity of the SUMO-1 activating enzyme, Furthermore, in an in vitro system, RanGAP1 was modified by SUMO-1 in the presence of Sua1p/Uba2p and hUbc9p, showing that the modification of SUMO-1 could be catalyzed by two enzyme steps, although ubiquitination usually requires three enzyme steps. (C) 1999 Academic Press.
引用
收藏
页码:693 / 698
页数:6
相关论文
共 30 条
[1]   Interaction of Fas(Apo-1/CD95) with proteins implicated in the ubiquitination pathway [J].
Becker, K ;
Schneider, P ;
Hofmann, K ;
Mattmann, C ;
Tschopp, J .
FEBS LETTERS, 1997, 412 (01) :102-106
[2]  
Boddy MN, 1996, ONCOGENE, V13, P971
[3]   APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein [J].
Chow, NW ;
Korenberg, JR ;
Chen, XN ;
Neve, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (19) :11339-11346
[4]   THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY [J].
CIECHANOVER, A .
CELL, 1994, 79 (01) :13-21
[5]   SUMO-1 modification of IκBα inhibits NF-κB activation [J].
Desterro, JMP ;
Rodriguez, MS ;
Hay, RT .
MOLECULAR CELL, 1998, 2 (02) :233-239
[6]   Ubch9 conjugates SUMO but not ubiquitin [J].
Desterro, JMP ;
Thomson, J ;
Hay, RT .
FEBS LETTERS, 1997, 417 (03) :297-300
[7]   AN ESSENTIAL YEAST GENE ENCODING A HOMOLOG OF UBIQUITIN-ACTIVATING ENZYME [J].
DOHMEN, RJ ;
STAPPEN, R ;
MCGRATH, JP ;
FORROVA, H ;
KOLAROV, J ;
GOFFEAU, A ;
VARSHAVSKY, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (30) :18099-18109
[8]   Fission yeast Cut2 required for anaphase has two destruction boxes [J].
Funabiki, H ;
Yamano, H ;
Nagao, K ;
Tanaka, H ;
Yasuda, H ;
Hunt, T ;
Yanagida, M .
EMBO JOURNAL, 1997, 16 (19) :5977-5987
[9]   MOLECULAR-CLONING, SEQUENCE, AND TISSUE DISTRIBUTION OF THE HUMAN UBIQUITIN-ACTIVATING ENZYME-E1 [J].
HANDLEY, PM ;
MUECKLER, M ;
SIEGEL, NR ;
CIECHANOVER, A ;
SCHWARTZ, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (01) :258-262
[10]   mUBC9, a novel adenovirus E1A-interacting protein that complements a yeast cell cycle defect [J].
Hateboer, G ;
Hijmans, EM ;
Nooij, JBD ;
Schlenker, S ;
Jentsch, S ;
Bernards, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (42) :25906-25911